Literature DB >> 7950590

Cardioprotective effect of hormone replacement therapy. Is not due to selection bias.

M Stampfer, F Grodstein.   

Abstract

Mesh：

Year:  1994        PMID： 7950590      PMCID： PMC2541034          DOI： 10.1136/bmj.309.6957.808b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

Authors:  W F Posthuma; R G Westendorp; J P Vandenbroucke
Journal:  BMJ       Date:  1994-05-14

2.  Hormone replacement therapy. Should be used selectively.

Authors:  J C Stevenson; M Baum
Journal:  BMJ       Date:  1994-07-16

3.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

Authors:  M J Stampfer; G A Colditz; W C Willett; J E Manson; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245
  3 in total
  4 in total

Review 1.  G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling.

Authors:  Bengt-Olof Nilsson; Björn Olde; L M Fredrik Leeb-Lundberg
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

2.  The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice.

Authors:  C Pendaries; B Darblade; P Rochaix; A Krust; P Chambon; K S Korach; F Bayard; J F Arnal
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

3.  Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production.

Authors:  J F Arnal; S Clamens; C Pechet; A Negre-Salvayre; C Allera; J P Girolami; R Salvayre; F Bayard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

4.  Estrogen Receptor-α Non-Nuclear Signaling Confers Cardioprotection and Is Essential to cGMP-PDE5 Inhibition Efficacy.

Authors:  Nobuaki Fukuma; Eiki Takimoto; Kazutaka Ueda; Pangyen Liu; Miyu Tajima; Yu Otsu; Taro Kariya; Mutsuo Harada; Haruhiro Toko; Kaori Koga; Robert M Blanton; Richard H Karas; Issei Komuro
Journal:  JACC Basic Transl Sci       Date:  2020-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.